Home LiteratureArticle Details
PMID: 6147723 Published · ppublish English Clinical Trial Comparative Study Controlled Clinical Trial Letter

Relapse rates in duodenal ulcer patients formerly treated with bismuth subcitrate or maintained with cimetidine.

Lancet (London, England) ·Vol. 2 ·No. 8404 ·1984-09-22 ·Pages 698

Bianchi Porro G, Lazzaroni M, Petrillo M, De Nicola C

Abstract

暂无摘要

MeSH Terms
Adult Antacids/therapeutic use Anti-Ulcer Agents/therapeutic use Bismuth/therapeutic use Cimetidine/therapeutic use Clinical Trials as Topic Double-Blind Method Duodenal Ulcer/drug therapy Female Follow-Up Studies Humans Male Middle Aged Organometallic Compounds Recurrence
Chemicals
Antacids Anti-Ulcer Agents Organometallic Compounds Cimetidine bismuth tripotassium dicitrate Bismuth
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Bianchi Porro G
Lazzaroni M
Petrillo M
De Nicola C
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
DOI
10.1016/s0140-6736(84)91258-3
Published
1984-09-22
Pages
698
Language
English
Region
England
NLM ID
2985213R
Subset
IM
External Links
PubMed source DOI: 10.1016/s0140-6736(84)91258-3 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2